Patents by Inventor Andrew John Kenny

Andrew John Kenny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220348641
    Abstract: The present disclosure relates to a method for the manufacture of recombinant antibody molecules comprising culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule; adding an extraction buffer to the sample; and subjecting the sample to a heat treatment step; wherein the pH of the sample is detected after addition of the extraction buffer, and optionally adjusted, to ensure that the pH of the sample is 6 to 9 prior to the heat treatment step.
    Type: Application
    Filed: July 6, 2022
    Publication date: November 3, 2022
    Inventors: JEAN-PASCAL PIERRE BILGISCHER, PHILIP JONATHAN BASSETT, MARK ROBERT PEARCE-HIGGINS, ANDREW JOHN KENNY
  • Patent number: 11384136
    Abstract: The present disclosure relates to a method for the manufacture of recombinant antibody molecules comprising culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule; adding an extraction buffer to the sample; and subjecting the sample to a heat treatment step; wherein the pH of the sample is detected after addition of the extraction buffer, and optionally adjusted, to ensure that the pH of the sample is 6 to 9 prior to the heat treatment step.
    Type: Grant
    Filed: November 5, 2019
    Date of Patent: July 12, 2022
    Assignee: UCB BIOPHARMA SRL
    Inventors: Jean-Pascal Pierre Bilgischer, Philip Jonathan Bassett, Mark Robert Pearce-Higgins, Andrew John Kenny
  • Publication number: 20200071387
    Abstract: The present disclosure relates to a method for the manufacture of recombinant antibody molecules comprising culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule; adding an extraction buffer to the sample; and subjecting the sample to a heat treatment step; wherein the pH of the sample is detected after addition of the extraction buffer, and optionally adjusted, to ensure that the pH of the sample is 6 to 9 prior to the heat treatment step.
    Type: Application
    Filed: November 5, 2019
    Publication date: March 5, 2020
    Inventors: JEAN-PASCAL PIERRE BILGISCHER, PHILIP JONATHAN BASSETT, MARK ROBERT PEARCE-HIGGINS, ANDREW JOHN KENNY
  • Patent number: 10487136
    Abstract: The present disclosure relates to a method for the manufacture of recombinant antibody molecules comprising culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule; adding an extraction buffer to the sample; and subjecting the sample to a heat treatment step; wherein the pH of the sample is detected after addition of the extraction buffer, and optionally adjusted, to ensure that the pH of the sample is 6 to 9 prior to the heat treatment step.
    Type: Grant
    Filed: February 2, 2011
    Date of Patent: November 26, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Jean-Pascal Pierre Bilgischer, Philip Jonathan Bassett, Mark Robert Pearce-Higgins, Andrew John Kenny
  • Publication number: 20130060009
    Abstract: The present disclosure relates to a method for the manufacture of recombinant antibody molecules comprising culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule; adding an extraction buffer to the sample; and subjecting the sample to a heat treatment step; wherein the pH of the sample is detected after addition of the extraction buffer, and optionally adjusted, to ensure that the pH of the sample is 6 to 9 prior to the heat treatment step.
    Type: Application
    Filed: February 2, 2011
    Publication date: March 7, 2013
    Inventors: Jean-Pascal Pierre Bilgischer, Philip Jonathan Bassett, Mark Robert Pearce-Higgins, Andrew John Kenny